SIGHT SCIENCES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
SIGHT SCIENCES, INC. (SGHT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $1.43 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-05
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $1.43, a 19.66% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $1.78, a 63.30% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $1.09, a 1.87% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.07.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $1.72, a 40.98% increase from fiscal 2024.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $1.22, a 18.45% increase from fiscal 2023.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $1.03, a 22.62% increase from fiscal 2022.
- SIGHT SCIENCES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $0.84, a 7.69% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.43 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $1.43 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $1.72 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $0.86 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $1.56 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $1.78 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $1.22 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $1.20 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $1.00 10-Q · filed 2024-08-02 | |||
| 2024-03-31 | $1.09 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | $1.03 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $1.68 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $1.52 10-Q · filed 2023-08-07 | |||
| 2023-03-31 | $1.07 10-Q · filed 2023-05-08 | |||
| 2022-12-31 | $0.84 10-K · filed 2023-03-16 | |||
| 2021-12-31 | $0.78 10-K · filed 2022-03-24 | |||
| 2021-06-30 | $0.94 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |